Neural Components Underlying the Treatment of Adolescent Depression
NCT ID: NCT01717508
Last Updated: 2020-02-24
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
NA
112 participants
INTERVENTIONAL
2012-10-31
2019-06-30
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
This study will also include healthy control participants. They will complete an initial assessment consisting of an interview, questionnaires, computer tasks, and an EEG recording. Three weeks later, they will return to complete a behavioral task while EEG data are recorded. Twelve weeks after the initial assessment, they will complete a final assessment, which will include questionnaires, computer tasks, and an EEG recording.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Cognitive Behavioral Therapy for Early-Onset Depression
NCT00096642
Internet Based Cognitive Behavioral Therapy Effects on Depressive Cognitions and Brain Function
NCT01598922
Predictors of Response to Treatment for Depression
NCT03154008
Neural Mechanisms of Family-Focused Treatment for Youth Depression
NCT06289010
Treatment of Post-TBI Depression
NCT00211835
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
NON_RANDOMIZED
PARALLEL
TREATMENT
NONE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Cognitive Behavioral Therapy
12 weekly sessions of cognitive behavioral therapy
Cognitive Behavioral Therapy
12 sessions of cognitive behavioral therapy
Healthy Controls
No interventions assigned to this group
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Cognitive Behavioral Therapy
12 sessions of cognitive behavioral therapy
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Female
* Current major depressive disorder (MDD) diagnosed according to the K-SADS Axis I semi-structured interview
* English as first language or English fluency
* Ages 13-18 years at time of initial assessment
* Female
* English as first language or English fluency
Exclusion Criteria
* Mania/Hypomania
* Current anxiety disorders \[e.g., Panic Disorder (PD), Generalized Anxiety Disorder (GAD), Obsessive Compulsive Disorder (OCD)\]
* Eating Disorders
* Substance Abuse/Dependency
* Conduct Disorder/Antisocial Disorder
* ADHD
* Psychosis
* Mental Retardation
* Organic Brain Syndrome
* Current Psychotherapy Treatment
* Medical \& neurological illness (head injury, loss of consciousness for more than 5 minutes, seizures)
* Current use of psychotropic medication for treatment of MDD with the exception of SSRIs (selective serotonin reuptake inhibitors)
* Active suicidality
* Elevated depressive symptoms as assessed in phone screen
13 Years
18 Years
FEMALE
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
National Institute of Mental Health (NIMH)
NIH
Mclean Hospital
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Randy P. Auerbach
Principal Investigator
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Randy P Auerbach, PhD
Role: PRINCIPAL_INVESTIGATOR
Mclean Hospital
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
McLean Hospital
Belmont, Massachusetts, United States
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
2011A053424
Identifier Type: OTHER_GRANT
Identifier Source: secondary_id
2011A051965
Identifier Type: OTHER_GRANT
Identifier Source: secondary_id
2010A054978
Identifier Type: OTHER_GRANT
Identifier Source: secondary_id
2012P001844
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.